-
Publication Venue For
-
Attempted lead extraction in low-risk patients without surgical backup: Progress or peril?.
18:1279-1280.
2021
-
Electrical storm in patients with left ventricular assist devices: Risk factors, incidence, and impact on survival..
18:1263-1271.
2021
-
Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices..
18:709-716.
2021
-
Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT..
18:399-403.
2021
-
Integrated electrophysiology care for patients with heart failure: An envisioned future..
18:e51-e63.
2021
-
Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker..
17:2056-2063.
2020
-
Predictors of atrial mechanical sensing and atrioventricular synchrony with a leadless ventricular pacemaker: Results from the MARVEL 2 Study..
17:2037-2045.
2020
-
Freedom from atrial fibrillation after catheter ablation: Survival of the fittest..
17:1694-1695.
2020
-
Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective..
17:1804-1832.
2020
-
Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review..
17:1536-1544.
2020
-
Impact of interruptions in radiofrequency energy delivery on lesion characteristics..
17:1354-1359.
2020
-
Reply to the Editor- Determinants of bipolar amplitude..
17:1415.
2020
-
Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice..
17:1057-1065.
2020
-
Mechanism and magnitude of bipolar electrogram directional sensitivity: Characterizing underlying determinants of bipolar amplitude..
17:777-785.
2020
-
Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE..
17:447-454.
2020
-
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias..
17:e2-e154.
2020
-
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary..
17:e155-e205.
2020
-
Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks..
17:98-105.
2020
-
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy..
16:e301-e372.
2019
-
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary..
16:e373-e407.
2019
-
2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society..
16:e227-e279.
2019
-
2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
16:e128-e226.
2019
-
HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs)..
16:e107-e127.
2019
-
Transparent sharing of digital health data: A call to action..
16:e95-e106.
2019
-
Prevalence of atrial fibrillation and association with clinical, sociocultural, and ancestral correlates among Hispanic/Latinos: The Hispanic Community Health Study/Study of Latinos..
16:686-693.
2019
-
The changing epidemiology of ventricular arrhythmias and sudden cardiac death: Is it a reality?.
16:367-368.
2019
-
Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery..
16:178-184.
2019
-
Vectorcardiographic QRS area is associated with long-term outcome after cardiac resynchronization therapy..
16:213-219.
2019
-
Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea..
16:91-97.
2019
-
Harmonized outcome measures for use in atrial fibrillation patient registries and clinical practice: Endorsed by the Heart Rhythm Society Board of Trustees..
16:e3-e16.
2019
-
Atrial fibrillation and obstructive lung disease: Don't fear the β-blocker..
15:1833-1834.
2018
-
Early experience with intravenous sotalol in children with and without congenital heart disease..
15:1862-1869.
2018
-
Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control..
15:1800-1807.
2018
-
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
15:e73-e189.
2018
-
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
15:e190-e252.
2018
-
Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
15:e253-e274.
2018
-
Atrial fibrillation mapping strategies: The hunt is on..
15:1304-1305.
2018
-
Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review..
15:1337-1345.
2018
-
Amino acid-level signal-to-noise analysis of incidentally identified variants in genes associated with long QT syndrome during pediatric whole exome sequencing reflects background genetic noise..
15:1042-1050.
2018
-
Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction..
15:651-657.
2018
-
Dofetilide dose reductions and discontinuations in women compared with men..
15:478-484.
2018
-
Reply to the Editor- Contact force-sensing catheters and increased risk of atrioesophageal fistula: Is the tool to blame or the workmen?.
15:e1-e2.
2018
-
Risk of atrioesophageal fistula formation with contact force-sensing catheters..
14:1328-1333.
2017
-
2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices..
14:e97-e153.
2017
-
Catheter ablation of para-Hisian atrial tachycardias: Is "earliest" still synonymous with "best"?.
14:1006-1007.
2017
-
Preventing heart failure in atrial fibrillation: In the middle of difficulty lies opportunity..
14:799-800.
2017
-
Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial..
14:685-691.
2017
-
The burden of proof: The current state of atrial fibrillation prevention and treatment trials..
14:763-782.
2017
-
Fragmentation and defragmenting: How to ablate in the age of connectivity?.
14:41-42.
2017
-
Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment..
13:2279-2286.
2016
-
Common human ANK2 variant confers in vivo arrhythmia phenotypes..
13:1932-1940.
2016
-
Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR..
13:1777-1783.
2016
-
Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials..
13:1748-1754.
2016
-
Extraction of chronically implanted coronary sinus leads active fixation vs passive fixation leads..
13:1253-1259.
2016
-
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
13:e136-e221.
2016
-
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
13:e92-135.
2016
-
Left atrial appendage characteristics and the risk of stroke: Sorting out the contenders from the pretenders..
13:828-829.
2016
-
Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: A systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society..
13:e222-e237.
2016
-
Junctophilin-2 at the intersection of arrhythmia and pathologic cardiac remodeling..
13:753-754.
2016
-
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing..
13:e50-e86.
2016
-
Proceedings from Heart Rhythm Society's emerging technologies forum, Boston, MA, May 12, 2015..
13:e39-e49.
2016
-
2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion)..
13:e3-e37.
2016
-
It's not the heart: autonomic nervous system predisposition to lethal ventricular arrhythmias..
12:2294-2295.
2015
-
Assessing the appropriateness of ICD use "appropriately"..
12:2094-2095.
2015
-
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death..
12:2058-2066.
2015
-
Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis..
12:2030-2037.
2015
-
Complications from prophylactic replacement of cardiac implantable electronic device generators in response to United States Food and Drug Administration recall: A systematic review and meta-analysis..
12:1558-1564.
2015
-
Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy..
12:1201-1208.
2015
-
COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm..
12:1105-1112.
2015
-
Cable externalization and electrical failure of the Riata family of implantable cardioverter-defibrillator leads: A systematic review and meta-analysis..
12:1233-1240.
2015
-
The association of left atrial low-voltage regions on electroanatomic mapping with low attenuation regions on cardiac computed tomography perfusion imaging in patients with atrial fibrillation..
12:857-864.
2015
-
Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks..
12:545-553.
2015
-
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013..
12:e5-e29.
2015
-
Novel mechanism of premature battery failure due to lithium cluster formation in implantable cardioverter-defibrillators..
11:2190-2195.
2014
-
Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes..
11:1991-1998.
2014
-
Sudden cardiac death after heart transplantation: can ICD prevent SCD?.
11:1691-1692.
2014
-
Treatment of atrial fibrillation in East Asia: what is perception and what is reality?.
11:1409-1410.
2014
-
Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial..
11:925-932.
2014
-
QRS fusion complex analysis using wave interference to predict reverse remodeling during cardiac resynchronization therapy..
11:806-813.
2014
-
FGF12 is a candidate Brugada syndrome locus..
10:1886-1894.
2013
-
A CACNA1C Mutation that Causes a Subset of Timothy Syndrome Phenotypes Correlates..
10:1745.
2013
-
Arrhythmogenic right ventricular cardiomyopathy: arrhythmias upstream and downstream..
10:1669-1670.
2013
-
Postmarket surveillance and returned product analysis: success but not transparency..
10:1469-1470.
2013
-
When to implant an ICD following a myocardial infarction?.
10:e79.
2013
-
Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?.
10:1127-1133.
2013
-
No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial..
10:970-976.
2013
-
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials..
10:828-835.
2013
-
The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy..
10:668-675.
2013
-
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance..
10:e11-e58.
2013
-
The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011..
10:e59-e65.
2013
-
Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants..
10:401-408.
2013
-
Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)..
10:193-199.
2013
-
Intracardiac acoustic radiation force impulse imaging: a novel imaging method for intraprocedural evaluation of radiofrequency ablation lesions..
9:1855-1862.
2012
-
Pharmacotherapy in Medicare beneficiaries with atrial fibrillation..
9:1403-1408.
2012
-
Early repolarization: a sword in the haystack?.
9:1301-1302.
2012
-
HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons..
9:1344-1365.
2012
-
BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes..
9:812-820.
2012
-
Atrial fibrillation and stroke: it's not necessarily all about the rhythm..
8:1424-1425.
2011
-
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS)..
8:1114-1154.
2011
-
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: executive summary this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS)..
8:e1-18.
2011
-
Pinning down the CaMKII targets in the L-type Ca(2+) channel: an essential step in defining CaMKII regulation..
8:631-633.
2011
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
8:e1-e8.
2011
-
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)..
8:393-400.
2011
-
Percutaneous intravascular defibrillator: preliminary data and many questions..
8:293-294.
2011
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
8:157-176.
2011
-
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial..
8:38-45.
2011
-
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure..
7:1340-1345.
2010
-
Surgically placed left ventricular leads provide similar outcomes to percutaneous leads in patients with failed coronary sinus lead placement..
7:619-625.
2010
-
RR-interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction..
7:65-71.
2010
-
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF..
6:1727-1734.
2009
-
GWAS or Gee Whiz, PSAS or Pshaw: elucidating the biologic and clinical significance of genetic variation in cardiovascular disease..
6:1751-1753.
2009
-
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study..
6:984-992.
2009
-
Prolonged RV endocardial activation duration: a novel marker of arrhythmogenic right ventricular dysplasia/cardiomyopathy..
6:769-775.
2009
-
Free radical scavenger specifically prevents ischemic focal ventricular tachycardia..
6:530-536.
2009
-
Acute and long-term efficacy and safety of catheter cryoablation of the cavotricuspid isthmus for treatment of type 1 atrial flutter..
5:1009-1014.
2008
-
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities..
5:e1-62.
2008
-
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary..
5:934-955.
2008
-
Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)..
5:807-813.
2008